100mg Erlonat Erlotinib Tablets

About 100mg Erlonat Erlotinib Tablets

Strength	100 mg
Composition	Erlotinib
Pack Type	Box
Brand	Erlonat
Packaging Size	30 tablets
Treatment	non-small cell lung cancer and pancreatic cancer.
Manufacturer	Natco

Erlonat 100mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.

Erlonat 100mg Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, vomiting, fatigue, rash, and weight loss. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. It makes you sensitive towards sunlight, hence wear protective clothing or use sunscreen while going out. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor. Your doctor may advise for regular monitoring of liver function while you are taking this medicine.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. It is advised to quit smoking while taking this medicine as it can affect the working of the medicine. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.

How Erlonat 100mg Tablets Work

Erlonat contains Erlotinib Hydrochloride, which selectively inhibits the epidermal growth factor receptor (EGFR). By blocking EGFR, it disrupts the signals cancer cells need to grow and divide. This targeted approach is commonly beneficial in treating certain lung and pancreatic cancers, making Erlonat a vital part of modern oncological therapy, especially for patients with metastatic non-small cell lung cancer (NSCLC).


Usage Guidelines and Administration

Erlonat 100mg should only be taken on the advice of a qualified oncologist. The recommended regimen is oral intake of one tablet daily on an empty stomach-at least one hour before or two hours after a meal. Consistent dosing time and adherence to medical instructions enhance the effectiveness of therapy and minimize potential risks. Regular laboratory monitoring is advised during treatment.


Safety Precautions and Patient Advice

Patients should diligently follow physician instructions and attend routine liver and kidney function tests to ensure safe therapy. Erlotinib may cause rash, diarrhea, loss of appetite, or fatigue-promptly consult your healthcare provider if you experience these or other side effects. The medication is contraindicated in cases of hypersensitivity to its components, and is generally not recommended during pregnancy or breastfeeding unless indispensable.